WEC
SURF

Winslow Evans & Crocker’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Winslow Evans & Crocker’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$5K Buy
+571
New +$4.96K ﹤0.01% 1112

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Winslow Evans & Crocker's SURF Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Surface Oncology, Inc. Common Stock (SURF) in Q4 2020: 571 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #1112 among its holdings.

91 funds tracked by Wall St. Rank hold SURF as of Q4 2020.

  • Winslow Evans & Crocker held 571 shares of Surface Oncology, Inc. Common Stock worth $5K as of Q4 2020.
  • Surface Oncology, Inc. Common Stock was a new Winslow Evans & Crocker position in Q4 2020.
  • Surface Oncology, Inc. Common Stock made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1112 holding.
  • 91 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.